Palantir's NHS Contract Under Political Pressure in the UK

Two parliamentary committees in the United Kingdom are exerting pressure on the Labour Party to terminate the critical £330 million (approximately $445 million) software contract between the US-based data analytics giant Palantir Technologies (PLTR) and the National Health Service (NHS). This call intensifies political tension, particularly regarding the next prime minister's approach to public sector deals. The joint demand from the Health and Social Care Select Committee and the Science, Innovation and Technology Committee aims for the NHS to find an alternative to Palantir's system, which is intended to unify and analyze vast amounts of sensitive NHS health data.

The current debate centers on Palantir's contract for the NHS Federated Data Platform (FDP), signed in 2023, with its initial three-year commitment ending in February 2027. Members of Parliament are urging the government to exercise a break clause at that time, citing "serious mistrust" among the public and medical profession, contested evidence of its benefits, and the availability of other tools that can deliver similar results. Furthermore, 117 NHS data and technology workers have also called for the deal to be scrapped, stating that patient privacy protections are inadequate, adding to the pressure. While Palantir maintains that its software delivers tangible benefits such as more NHS operations and improved military capabilities, critics raise concerns about over-reliance on a US firm and issues of data sovereignty.

This political pressure poses a significant risk to Palantir's financial outlook. The company's shares (PLTR) experienced a downturn in pre-market trading following news of the contract review. Potential contract cancellations, reputational damage, loss of future UK government contracts, and increased demands for transparency could jeopardize Palantir's UK public sector revenue and overall business prospects. In the most recent quarter, Palantir's UK sales amounted to approximately $130 million, accounting for about 8% of the company's total business. Analysts also suggest that the company's current valuation is overvalued by some metrics.

This development is viewed as part of a broader discussion in the UK regarding digital transformation and digital sovereignty. The government's reliance on a small number of major US technology providers for critical national infrastructure raises serious concerns about the country's data security and strategic autonomy. Palantir co-founder Peter Thiel's past comments on the NHS and the company's connections to US military and immigration agencies are also a significant part of these ongoing debates. Previously, some contracts with the Metropolitan Police were blocked due to breaches of procurement rules and value-for-money concerns.

In the upcoming period, markets will closely monitor how the new prime minister, expected to be from the Labour Party, will approach such agreements. Potential prime ministerial candidate Andy Burnham is reportedly disinclined to award future government work to Palantir. However, some experts suggest that replacing Palantir's system by the 2027 break clause date would be "very unrealistic," potentially creating operational risks. This highlights that while the government seeks an exit, it is also trying to leverage its position and address the crucial question of how to disengage from Palantir without hampering existing medical services.